Oral Oncology
Volume 38, Issue 1 , Pages 96-102 , January 2002

Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations

  • C.M. Flaitz

      Affiliations

    • Department of Stomatology, University of Texas-Houston Health Science Center, Dental Branch, 6516 John Freeman Avenue, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-713-500-4404; fax: +1-713-500-4416
    • ,
  • C.M. Nichols

      Affiliations

    • Dental Clinic, Bering Community Service Foundation, Houston, Texas, USA
    • ,
  • D.M. Walling

      Affiliations

    • Department of Internal Medicine, Division of Infectious Disease, University of Texas Medical Branch at Galveston, Galveston, Texas, USA
    • ,
  • M.J. Hicks

      Affiliations

    • Department of Pathology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA

Received 5 January 2001 ,Accepted 12 January 2001.

References 

  1. Levine AM. Effect of HAART on AIDS malignancies. Available at: www.medscape.com/Medscape/CNO/2000?AIDS/Story.html (accessed 15 July 2000).
  2. Laurence J. Update: editorial — AIDS malignancies, AIDS prevention. The AIDS Reader. 2000;10(7):388–389
  3. Appleby P, Beral V, Newton R, Reeves G. International Collaboration on HIV and Cancer (highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults). J Natl Cancer Inst. 2000;92:1823–1830
  4. Grulich AE. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. J Acquir. Immune Defic. Syndr. 1999;21(Suppl. 1):S27–S30
  5. Grulich AE. Cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy. The AIDS Reader. 2000;10:341–346
  6. Serraino D, Pezzotti P, Dorrucci M, Altlegro MB, Sinicco A, Rezza G. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. Cancer. 1997;79:1004–1008
  7. Jordan RC, Chong L, DiPierdomenico S, Satira F, Main JH. Oral lymphoma in HIV infection. Oral Diseases. 1997;3(Suppl. 1):S135–S137
  8. Franceschi S, Dal Maso L, La Vecchia C. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer. 1999;83:481–485
  9. Singh B, Poluri A, Shaha AR, Michuart P, Har-El G, Lucente FE. Head and neck manifestations of non-Hodgkin's lymphoma in human immunodeficiency virus-infected patients. Am J Otolaryngol. 2000;21:10–13
  10. Vazquez-Pinero T, Viana de Frias L, Cristobal E, Cosin J, Menarguez J. HIV-associated oral pleomorphic B-cell malignant lymphoma. Oral Surg, Oral Med Oral Pathol, Oral Radiol, Endod. 1997;84:142–145
  11. Cote TR, Biggar RJ, Rosenberg RS, Devesa SS, Percy C, Yellin FJ, et al. Non-Hodgkin's lymphoma among people with AIDS (incidence, presentation and public health burden). AIDS/Cancer study group. Int J Cancer. 1997;73:645–650
  12. Levine AM. AIDS-related lymphoma. HIV Clinical Management Volume 11. Available at: www.medscape.com/medscape/HIV/ClinicalMgmt/CM.v11/public/index-CM.vll.html (accessed 27 August 2000).
  13. Levine AM. 4th International AIDS malignancy conference. Medscape HIV/AIDS 6(3), 2000. Available at: www.medscape.com/Medcape/HIV/journal/v06.n03/mha0627.levi.levine-01.html (accessed 27 August 2000).
  14. Sparano JA, Anand K, Desai J, Mitnick RJ, Kalkut GE, Hanau LH. Effect of highly active antireteroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. J Acquir Immune Defic Syndr. 1999;21(Suppl. 1):S18–S22
  15. Calzolari A, Papucci A, Baroni G, Ficarra G, Porfirio B, Chiarelli I, et al. Epstein–Barr virus infection and p53 expression in HIV-related oral large B cell lymphoma. Head Neck. 1999;21:454–460
  16. Regezi JA, McMillan A, Dekker N, Daniels TE, Silverman S, Schoelch M, et al. Apoptosis-associated proteins in oral lymphomas from HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:196–202
  17. Katano H, Suda T, Morishita Y, Yamamoto K, Hoshino Y, Nakamura K, et al. Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology. Mod Pathol. 2000;13:77–85
  18. Dupin N, Diss TL, Kellam P, Tulliez M, Du M-Q, Sicard D, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406–1412
  19. Leao JC, Porter S, Scully C. Human herpesvirus 8 and oral health care (an update). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:694–704
  20. Carbone A, Gaidano G, Gloghini A, Ferlito A, Rinaldo A, Stein H. AIDS-related plasmablastic lymphoma of the oral cavity and jaws (a diagnostic dilemma). Ann Otol Rhinol Laryngol. 1999;108:95–99
  21. Porter SR, Dios PD, Kumar N, Stock C, Barrett AW, Scully C. Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:730–734
  22. Deleclues HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic lymphoma of the oral cavity (a new entity associated with the human immunodeficiency virus infection). Blood. 1997;89:1413–1420
  23. Brown RS, Campbell C, Lishman SC, Spittle MF, Miller RF. Plasmablastic lymphom (a new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma). Clin Oncol. 1998;10:327–329
  24. Bell PB, Rooney N, Bosanquet AG. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase. Cytometry (Comm Clin Cytometry). 1999;38:102–105
  25. Astsaturov IA, Matutes E, Morilla R, Seon BK, Mason DY, Farahat N, et al. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukemia. Leukemia. 1996;10:769–773
  26. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, et al  CD79a; a novel marker for B-cell noeplasms in routinely processed tissue samples. Blood. 1995;86:1453–1459
  27. Hashimoto S, Mohrenweiser HW, Gergersen PK, Chiorazzi N. Chromosomal localization, genomic structure, and allelic polymorphism of the human CD79 alpha (Ig-alpha/mb-1) gene. Immunogenetics. 1994;40:287–295
  28. Delecluse HJ, Hummel M, Marafioti T, Anagnostopoulos I, Stein H. Common and HIV-related diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern. J Pathol. 1999;188:133–138
  29. Dhodapkar MV, Sanderson RD. Syndecan-1 (CD138) in myeloma and lymphoid malignancies (a multifunctional regulator of cell behavior within the tumor microenvironment). Leuk Lymphoma. 1999;34:35–43
  30. Chilosi M, Adami F, Lestani M, Montagna L, Cimarosto L, Semenzato G, et al. CD138/syndecan-1 (a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies). Mod Pathol. 1999;12:1101–1106

PII: S1368-8375(01)00018-5

Oral Oncology
Volume 38, Issue 1 , Pages 96-102 , January 2002

Article Tools

* Image Usage & Resolution